» Authors » Terry L Moore

Terry L Moore

Explore the profile of Terry L Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 1071
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Richardson T, Clarke C, Yu K, Yee Y, Bleisch T, Lopez J, et al.
ACS Med Chem Lett . 2014 Jun; 2(2):148-53. PMID: 24900294
We report the synthesis and characterization of novel 3-aryl indoles as potent and efficacious progesterone receptor (PR) antagonists with potential for the treatment of uterine fibroids. These compounds demonstrated excellent...
12.
Gilliam B, Chauhan A, Moore T
Pediatr Rheumatol Online J . 2013 Aug; 11(1):31. PMID: 23987731
Background: To determine the prevalence and significance of anti-citrullinated vimentin and anti-citrullinated type II collagen antibodies and elucidate their role in the disease process of juvenile idiopathic arthritis (JIA). Methods:...
13.
Gilliam B, Moore T
Expert Opin Med Diagn . 2013 Mar; 6(4):359-69. PMID: 23480744
Introduction: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and the presence of self-reactive autoantibodies. Since the discovery of anti-cyclic citrullinated peptide (anti-CCP) antibodies, several assays have...
14.
Gibson D, Newell K, Evans A, Finnegan S, Manning G, Scaife C, et al.
J Proteomics . 2012 Jul; 75(17):5479-92. PMID: 22771520
Introduction: Juvenile idiopathic arthritis (JIA) comprises a poorly understood group of chronic autoimmune diseases with variable clinical outcomes. We investigated whether the synovial fluid (SF) proteome could distinguish a subset...
15.
Gilliam B, Ombrello A, Burlingame R, Pepmueller P, Moore T
Semin Arthritis Rheum . 2011 Dec; 41(6):840-8. PMID: 22177108
Objective: To evaluate an autoantibody profile in pediatric-onset systemic lupus erythematosus (SLE) patients to determine clinical and statistical associations with disease-associated manifestations. Methods: Sera from 53 SLE patients and 22...
16.
Gilliam B, Reed M, Chauhan A, Dehlendorf A, Moore T
Clin Exp Rheumatol . 2011 Dec; 29(6):1049-56. PMID: 22153664
Objectives: Immune complexes (ICs) from sera of juvenile idiopathic arthritis (JIA) patients show increased complement opsonisation; however, a definitive role for involvement of the classical or alternative pathway is not...
17.
Chauhan A, Moore T
J Biol Chem . 2011 Sep; 286(44):38627-38637. PMID: 21900254
T cell hyperactivation and complement consumption are prominent features of the immunopathology of systemic lupus erythematosus. Although complement activation is secondary to autoantibodies that form immune complexes (ICs), the trigger...
18.
Gilliam B, Reed M, Chauhan A, Dehlendorf A, Moore T
Pediatr Rheumatol Online J . 2011 Mar; 9:8. PMID: 21439056
Background: Several studies have noted the significance of measuring anti-cyclic citrullinated peptide (CCP) antibodies in juvenile idiopathic arthritis (JIA) as an important indicator for destructive disease, as is the case...
19.
Ma Y, Zeng Q, Porras L, Harvey A, Moore T, Shelbourn T, et al.
Endocrinology . 2011 Feb; 152(5):1767-78. PMID: 21343258
We compared teriparatide (TPTD) and strontium ranelate (SR) efficacy on bone formation activity in a mature rat model of estrogen-deficiency bone loss. Rats were ovariectomized (OVX) at age 6 months...
20.
Low J, Chauhan A, Gibson D, Zhu M, Chen S, Rooney M, et al.
Proteomics Clin Appl . 2010 Dec; 3(7):829-40. PMID: 21136990
Juvenile idiopathic arthritis reflects a group of clinically heterogeneous arthritides hallmarked by elevated concentrations of circulating immune complexes. In this study, the circulating immune complex proteome was examined to elucidate...